Hermeus Aircraft - Hermeus, a company looking to build a Mach 5 jet that will make the trip from New York to London in just 90 minutes, has raised a $16 million Series A round led by Canaan Partners and includes participation from existing investors Khosla Ventures , Bling capital and recovery of pension funds. The new funding will help the startup build and test its first fully operational engine, the key elements that will power its first Mach 5 aircraft.
Earlier this year, Hermeus was able to successfully demonstrate a subscale generator, showing that the design of its technology is complete as expected. The company now plans to turn that into an engine that matches its production and power, while also expanding the footprint of its Atlanta test site to include some light house production. It will continue to work on its debut plane, and said it will share more information about the first plane in the coming months.
Hermeus Aircraft

Hermeus says its goal of Mach 5 flight is achievable with mature technology already on the market, and it calls on a team with experience from a wide range of companies. SpaceX, Blue Origin, NASA, Boeing and others. competitive advantage.
Photos: No Name Firm Wins Contract To Develop Us Hypersonic Air Force One Jet
But 5. The Concorde flies at speeds above Mach 2, and the startup Boom Aerospace is aiming for Mach 2.2 for its commercial opening supersonic plane. NASA's X-59 experimental supersonic jet, built by Lockheed Martin, will cruise at a speed of Mach 1.42. Mach 5 will obviously be a bit faster than even the most ambitious of these projects, but Hermeus CEO AJ Piplica said the company previously expected it would take about ten years of development before building commercial planes.
Aircraft appraisal online, free aircraft appraisal, aircraft appraisal services, aircraft appraisal cost, aircraft appraisal jobs, aircraft appraisal course, aircraft appraisal training, business appraisal, rolex appraisal, appraisal software, 409a appraisal, aircraft appraisal report
Post A Comment:
0 comments so far,add yours